Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Reduced C-peptide level, Polyneuropathy, Moderate albuminuria, and Maturity-onset diabetes of the young and others. 14 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 2 | Transient neonatal diabetes mellitus, Maturity-onset diabetes of the young |
Biomarker and diagnostic research for maturity-onset diabetes of the young, type 12 has been reported in the published literature.
Phenotype severity distribution: 8 always present features.
No clinical trials have been registered for maturity-onset diabetes of the young, type 12.
44 publications have been identified in PubMed for maturity-onset diabetes of the young, type 12. Research spans Case Report / Case Series (34%), Basic Science / Preclinical (23%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:40 PM UTC
Online Mendelian Inheritance in Man
Brain and nerves
1 |
Polyneuropathy |
Pregnancy and birth | 1 | Transient neonatal diabetes mellitus |
Heart and blood vessels | 1 | Hypertension |
Blood and immune system | 1 | Elevated hemoglobin A1c |
Eyes | 1 | Damage to the retina (retinopathy) |
Metabolism | 1 | Abnormal blood fat levels (abnormal circulating lipid concentration) |
Bones and joints | 1 | Bone infection (osteomyelitis) |
Laboratory research
10 |
23% |
Research summaries | 7 | 16% |
Disease patterns and progression | 7 | 16% |
Testing and diagnosis research | 3 | 7% |
Other research | 1 | 2% |
Clinical study results | 1 | 2% |
Tovar A (2026). [PMID: 41952336](https://pubmed.ncbi.nlm.nih.gov/41952336/). *HGG Adv*. [Basic Science / Preclinical]
Yaman MK (2026). [PMID: 42220599](https://pubmed.ncbi.nlm.nih.gov/42220599/). *JCEM Case Rep*. [Case Report / Case Series]
Laver TW (2026). [PMID: 41772234](https://pubmed.ncbi.nlm.nih.gov/41772234/). *Diabetologia*. [Review / Meta-Analysis]
Thewjitcharoen Y (2026). [PMID: 41694565](https://pubmed.ncbi.nlm.nih.gov/41694565/). *Front Endocrinol (Lausanne)*. [Epidemiology / Natural History]
Chen Y (2026). [PMID: 41679598](https://pubmed.ncbi.nlm.nih.gov/41679598/). *Diabetes Metab*. [Basic Science / Preclinical]
Relan S (2026). [PMID: 40554608](https://pubmed.ncbi.nlm.nih.gov/40554608/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Umeda C (2026). [PMID: 42158912](https://pubmed.ncbi.nlm.nih.gov/42158912/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Su C (2026). [PMID: 41658513](https://pubmed.ncbi.nlm.nih.gov/41658513/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Han M (2025). [PMID: 40629618](https://pubmed.ncbi.nlm.nih.gov/40629618/). *Medicine (Baltimore)*. [Case Report / Case Series]
Tovar A (2025). [PMID: 37873175](https://pubmed.ncbi.nlm.nih.gov/37873175/). *bioRxiv*. [Basic Science / Preclinical]